calumet - CLMT

CLMT

Close Chg Chg %
20.42 -0.96 -4.70%

Open Market

19.46

-0.96 (4.70%)

Volume: 375.29K

Last Updated:

Dec 16, 2025, 3:24 PM EDT

Company Overview: calumet - CLMT

CLMT Key Data

Open

$19.80

Day Range

19.40 - 20.49

52 Week Range

7.68 - 23.75

Market Cap

$1.77B

Shares Outstanding

86.75M

Public Float

67.41M

Beta

1.18

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$0.44

Yield

0.00%

Dividend

$0.69

EX-DIVIDEND DATE

Jan 29, 2016

SHORT INTEREST

N/A

AVERAGE VOLUME

569.61K

 

CLMT Performance

1 Week
 
-0.20%
 
1 Month
 
9.37%
 
3 Months
 
10.32%
 
1 Year
 
0.15%
 
5 Years
 
438.79%
 

CLMT Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 5
Full Ratings ➔

About calumet - CLMT

Calumet, Inc. engages in the manufacturing, formulation, and sale of specialty branded products and renewable fuel. It operates through the following segments: Specialty Products and Solutions, Montana/Renewables, Performance Brands, and Corporate. The Specialty Products & Solutions segment consists of customer-focused solutions and formulation businesses. The Montana/Renewables segment is composed of a Great Falls specialty asphalt facility and Montana Renewables facility. The Performance Brands segment includes Royal Purple, Bel-Ray, and TruFuel. The Corporate segment focuses on the general and administrative expenses not allocated to other segments. The company was founded in 1919 and is headquartered in Indianapolis, IN.

CLMT At a Glance

Calumet, Inc.
1060 North Capitol Avenue
Indianapolis, Indiana 46204-1044
Phone 1-317-328-5660 Revenue 4.19B
Industry Oil Refining/Marketing Net Income -222,000,000.00
Sector Energy Minerals 2024 Sales Growth 0.201%
Fiscal Year-end 12 / 2025 Employees 1,620
View SEC Filings

CLMT Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 0.437
Price to Book Ratio N/A
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA 20.322
Enterprise Value to Sales 1.051
Total Debt to Enterprise Value 0.539

CLMT Efficiency

Revenue/Employee 2,586,049.383
Income Per Employee -137,037.037
Receivables Turnover 15.064
Total Asset Turnover 1.521

CLMT Liquidity

Current Ratio 0.887
Quick Ratio 0.405
Cash Ratio 0.053

CLMT Profitability

Gross Margin 5.977
Operating Margin 0.709
Pretax Margin -5.28
Net Margin -5.299
Return on Assets -8.059
Return on Equity N/A
Return on Total Capital -13.363
Return on Invested Capital -15.247

CLMT Capital Structure

Total Debt to Total Equity N/A
Total Debt to Total Capital 142.852
Total Debt to Total Assets 86.042
Long-Term Debt to Equity N/A
Long-Term Debt to Total Capital 135.25
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Calumet - CLMT

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
3.15B 4.69B 4.18B 4.19B
Sales Growth
+38.79% +48.88% -10.79% +0.20%
Cost of Goods Sold (COGS) incl D&A
3.01B 4.34B 3.68B 3.94B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
124.70M 121.30M 182.90M 187.00M
Depreciation
95.90M 88.70M 139.00M 142.50M
Amortization of Intangibles
11.80M 9.50M 7.80M 6.50M
COGS Growth
+46.28% +44.28% -15.16% +7.08%
Gross Income
142.90M 350.80M 502.30M 250.40M
Gross Income Growth
-33.16% +145.49% +43.19% -50.15%
Gross Profit Margin
+4.54% +7.49% +12.01% +5.98%
2021 2022 2023 2024 5-year trend
SG&A Expense
203.90M 194.90M 187.90M 201.20M
Research & Development
- - - -
-
Other SG&A
203.90M 194.90M 187.90M 201.20M
SGA Growth
-18.11% -4.41% -3.59% +7.08%
Other Operating Expense
20.70M 21.80M (6.90M) 19.50M
Unusual Expense
28.50M 88.00M 37.30M 30.80M
EBIT after Unusual Expense
(110.20M) 46.10M 284.00M (1.10M)
Non Operating Income/Expense
1.10M (38.60M) (12.60M) 16.60M
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
149.50M 175.90M 221.70M 236.70M
Interest Expense Growth
+18.75% +17.66% +26.04% +6.77%
Gross Interest Expense
151.10M 194.50M 225.10M 238.80M
Interest Capitalized
1.60M 18.60M 3.40M 2.10M
Pretax Income
(258.60M) (168.40M) 49.70M (221.20M)
Pretax Income Growth
-74.85% +34.88% +129.51% -545.07%
Pretax Margin
-8.21% -3.59% +1.19% -5.28%
Income Tax
1.50M 3.40M 1.60M 800.00K
Income Tax - Current - Domestic
- - - -
-
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
- - - -
-
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(260.10M) (171.80M) 48.10M (222.00M)
Minority Interest Expense
- (5.20M) (10.00M) 1.00M
Net Income
(254.90M) (161.80M) 47.10M (222.00M)
Net Income Growth
-74.59% +36.52% +129.11% -571.34%
Net Margin Growth
-8.10% -3.45% +1.13% -5.30%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(254.90M) (161.80M) 47.10M (222.00M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(254.90M) (161.80M) 47.10M (222.00M)
EPS (Basic)
-3.2274 -2.0394 0.5882 -2.67
EPS (Basic) Growth
-73.24% +36.81% +128.84% -553.93%
Basic Shares Outstanding
78.98M 79.34M 80.08M 83.15M
EPS (Diluted)
-3.2274 -2.0394 0.5882 -2.67
EPS (Diluted) Growth
-73.24% +36.81% +128.84% -553.93%
Diluted Shares Outstanding
78.98M 79.34M 80.08M 83.15M
EBITDA
43.00M 255.40M 504.20M 216.70M
EBITDA Growth
-26.50% +493.95% +97.42% -57.02%
EBITDA Margin
+1.37% +5.45% +12.06% +5.17%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 21.45
Number of Ratings 5 Current Quarters Estimate -0.223
FY Report Date 12 / 2025 Current Year's Estimate -0.18
Last Quarter’s Earnings 3.61 Median PE on CY Estimate N/A
Year Ago Earnings -2.67 Next Fiscal Year Estimate -0.331
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 4 2 4 4
Mean Estimate -0.22 -0.10 -0.18 -0.33
High Estimates 0.20 0.33 0.26 2.35
Low Estimate -0.77 -0.54 -0.73 -1.27
Coefficient of Variance -219.71 -594.52 -275.65 -539.82

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 3 3 3
OVERWEIGHT 0 0 0
HOLD 2 2 3
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Calumet - CLMT

Date Name Shares Transaction Value
Mar 14, 2025 Stephen Patrick Mawer Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 14, 2025 Scott Obermeier EVP - SPECIALTIES 224,150 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 0.00
Mar 14, 2025 Scott Obermeier EVP - SPECIALTIES 238,143 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 14, 2025 Bruce A. Fleming EVP - MONTANA RENEWABLES N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 14, 2025 Bruce A. Fleming EVP - MONTANA RENEWABLES 587,498 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 0.00
Mar 14, 2025 Bruce A. Fleming EVP - MONTANA RENEWABLES 655,693 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 14, 2025 Louis Todd Borgmann CHIEF EXECUTIVE OFFICER 235,566 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 0.00
Mar 14, 2025 Gregory J. Morical SVP, GENERAL COUNSEL N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 14, 2025 Scott Obermeier EVP - SPECIALTIES N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 14, 2025 Gregory J. Morical SVP, GENERAL COUNSEL 89,479 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 14, 2025 Stephen Patrick Mawer Director 290,962 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 0.00
Mar 14, 2025 Stephen Patrick Mawer Director 366,835 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 14, 2025 Vincent Donargo Chief Accounting Officer N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 14, 2025 Vincent Donargo Chief Accounting Officer 14,005 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 0.00
Mar 14, 2025 Vincent Donargo Chief Accounting Officer 18,149 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 14, 2025 Louis Todd Borgmann CHIEF EXECUTIVE OFFICER N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 14, 2025 Gregory J. Morical SVP, GENERAL COUNSEL 64,538 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 0.00
Mar 14, 2025 Louis Todd Borgmann CHIEF EXECUTIVE OFFICER 285,533 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 6, 2025 David A. Lunin EVP - CFO 2,500 Open market or private purchase of non-derivative security Non-derivative transaction at $13.05 per share 32,625.00
Feb 28, 2025 Amy M. Schumacher Director 517 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Calumet in the News